Point72 Asia (Singapore)’s Acumen Pharmaceuticals ABOS Stock Holding History

Point72 Asia (Singapore)’s Portfolio ABOS Stock Details ABOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$27.4K	Sell	16,044 -5,296	-25%	-$7.33K	﹤0.01%	657
2025 Q2	$24.8K	Buy	+21,340	New	+$22.9K	﹤0.01%	705
2024 Q2	–	Sell	-27,556	Closed	-$112K	–	1012
2024 Q1	$112K	Buy	27,556 +25,556	+1,278%	+$96.3K	0.03%	611
2023 Q4	$7.68K	Buy	+2,000	New	+$5.94K	﹤0.01%	513

Other funds holding ABOS

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

SCV

Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KIA

Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

Point72 Asia (Singapore)'s ABOS Position: Q3 2025 in Review

Point72 Asia (Singapore) reduced its Acumen Pharmaceuticals (ABOS) stake by 25% in Q3 2025, selling an estimated $7.33K and leaving 16,044 shares worth $27.4K. The position accounts for ﹤0.01% of the portfolio, ranked #657.

Point72 Asia (Singapore) first reported a position in ABOS in Q4 2023 and has held it in 4 quarters since. The position peaked at $112K in Q1 2024. 69 funds tracked by Wall St. Rank hold ABOS as of Q3 2025.

Point72 Asia (Singapore) held 16,044 shares of Acumen Pharmaceuticals worth $27.4K as of Q3 2025.
Point72 Asia (Singapore) sold 5,296 Acumen Pharmaceuticals shares in Q3 2025, an estimated $7.33K.
Acumen Pharmaceuticals made up ﹤0.01% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #657 holding.
Point72 Asia (Singapore) first reported a position in Acumen Pharmaceuticals in Q4 2023 and has held it in 4 quarters since.
Point72 Asia (Singapore)'s Acumen Pharmaceuticals position peaked at $112K in Q1 2024.
69 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.